DSP Nifty Healthcare Index Fund Direct-Growth
Equity: Sectoral-Pharma - Growth (Open ended) Factsheet
SEBI Riskometer: Very HighCategory: Equity: Sectoral-PharmaBenchmark: NIFTY Healthcare Total Return Index.
NAV: ₹11.73-0.08%
16 Jul 2026
Loading…
| Asset | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Equity | 99.94% | 99.41% | 99.44% | 99.17% | 99.75% | 99.65% |
| Debt | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Others (incl. cash) | 0.06% | 0.59% | 0.56% | 0.83% | 0.25% | 0.35% |
| Commodities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Real Estate | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Instrument | Sector | No. of Shares | Value (Rs. Cr) | Weight | Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 21,316 | 3.97 | 18.13% | -0.14%↓ |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 2,071 | 1.8 | 8.21% | 0.14%↑ |
| Max Healthcare Institute Ltd. | Healthcare | 14,982 | 1.69 | 7.73% | 0.84%↑ |
| Divis Laboratories Ltd. | Healthcare | 2,558 | 1.68 | 7.69% | -0.43%↓ |
| Dr. Reddys Laboratories Ltd. | Healthcare | 12,271 | 1.67 | 7.61% | -0.01%↓ |
| Cipla Ltd. | Healthcare | 11,327 | 1.66 | 7.58% | 0.02%↑ |
| Laurus Labs Ltd. | Healthcare | 7,832 | 1.19 | 5.43% | 0.35%↑ |
| Lupin Ltd. | Healthcare | 4,888 | 1.18 | 5.40% | 0.13%↑ |
| Fortis Healthcare Ltd. | Healthcare | 10,490 | 1 | 4.58% | -0.06%↓ |
| Torrent Pharmaceuticals Ltd. | Healthcare | 2,112 | 0.98 | 4.46% | 0.04%↑ |
| Aurobindo Pharma Ltd. | Healthcare | 5,572 | 0.88 | 4.02% | 0.20%↑ |
| Glenmark Pharmaceuticals Ltd. | Healthcare | 3,031 | 0.67 | 3.05% | -0.23%↓ |
| Alkem Laboratories Ltd. | Healthcare | 1,177 | 0.66 | 2.99% | -0.09%↓ |
| Biocon Ltd. | Healthcare | 14,362 | 0.6 | 2.74% | -0.19%↓ |
| Mankind Pharma Ltd. | Healthcare | 2,279 | 0.58 | 2.65% | 0.07%↑ |
| Zydus Lifesciences Ltd. | Healthcare | 5,036 | 0.56 | 2.56% | -0.03%↓ |
| Ipca Laboratories Ltd. | Healthcare | 2,796 | 0.48 | 2.17% | 0.14%↑ |
| Abbott India Ltd. | Healthcare | 104 | 0.26 | 1.21% | -0.12%↓ |
| Piramal Pharma Ltd. | Healthcare | 12,521 | 0.21 | 0.96% | -0.07%↓ |
| Syngene International Ltd. | Healthcare | 3,827 | 0.17 | 0.77% | -0.03%↓ |
| Sector | 30 Jun 2026 | 31 May 2026 | 30 Apr 2026 | 31 Mar 2026 | 28 Feb 2026 | 31 Jan 2026 |
|---|---|---|---|---|---|---|
| Healthcare | 99.94% | 99.41% | 99.44% | 99.17% | 99.75% | 99.65% |
30.5 / 100
Weighted average Value score is 30.5. This indicates that portfolio is relatively reasonably valued using composite of value measures.
78.9 / 100
Weighted average Price Momentum score is 78.9. This indicates that portfolio has high momentum using composite of momentum measures.
87.8 / 100
Weighted average Quality score is 87.8. This indicates that portfolio has high quality using composite of quality measures.
78.6 / 100
Weighted average QVM score is 78.6. This indicates that portfolio has high QVM score and hence could be considered for investment.